Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX Model

BACKGROUND: The morbidity and mortality of gastric cancer are high in China. There are challenges to develop precise and individualized drug regimens for patients with gastric cancer after a standard treatment. Choosing the most appropriate anticancer drug after a patient developing drug resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianzheng, Huang, Jinxi, Wang, Hui, Yang, Wei, Bai, Qiwen, Yao, Zhentao, Li, Qingli, Lv, Huifang, Chen, Beibei, Nie, Caiyun, Xu, Weifeng, Tu, Shuiping, Li, Hongle, Chen, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813284/
https://www.ncbi.nlm.nih.gov/pubmed/35126513
http://dx.doi.org/10.1155/2022/1987705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813284/
https://www.ncbi.nlm.nih.gov/pubmed/35126513
http://dx.doi.org/10.1155/2022/1987705

Ejemplares similares